The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Review article: anti‐inflammatory mechanisms of action of Saccharomyces boulardii
Open accessAbstract
Aliment Pharmacol Ther 30, 826–833 Summary: Background Saccharomyces boulardii, a well‐studied probiotic, can be effective in inflammatory gastrointestinal diseases with diverse pathophysiology, such as inflammatory bowel disease (IBD), and bacterially mediated or enterotoxin‐mediated diarrhoea and inflammation. Aim To discuss the mechanisms of action involved in the intestinal anti‐inflammatory action of S. boulardii. Methods Review of the literature related to the anti‐inflammatory effects of this probiotic. Results Several mechanisms of action have been identified directed against the host and pathogenic microorganisms. S. boulardii and S. boulardii secreted‐protein(s) inhibit production of proinflammatory cytokines by interfering with the global mediator of inflammation nuclear factor κB, and modulating the activity of the mitogen‐activated protein kinases ERK1/2 and p38. S. boulardii activates expression of peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) that protects from gut inflammation and IBD. S. boulardii also suppresses ‘bacteria overgrowth’ and host cell adherence, releases a protease that cleaves C. difficile toxin A and its intestinal receptor and stimulates antibody production against toxin A. Recent results indicate that S. boulardii may interfere with IBD pathogenesis by trapping T cells in mesenteric lymph nodes. Conclusions The multiple anti‐inflammatory mechanisms exerted by S. boulardii provide molecular explanations supporting its effectiveness in intestinal inflammatory states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
McFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872
PPARγ as a new therapeutic target in inflammatory bowel diseases
Dubuquoy, L., Rousseaux, C., Thuru, X., Peyrin-Biroulet, L., Romano, O., Chavatte, P., Chamaillard, M., & Desreumaux, P. (2006) · Gut · doi:10.1136/gut.2006.093484 · Cited by 450
Cited by
Microbial Ecology along the Gastrointestinal Tract
Hillman, E. T., Lu, H., Yao, T., & Nakatsu, C. H. (2017) · Microbes and environments · doi:10.1264/jsme2.me17017 · Cited by 580
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
McFarland, L. V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2202 · Cited by 545
Kelesidis, T., & Pothoulakis, C. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11428502 · Cited by 377
Self-citationAntimicrobial and Probiotic Properties of Yeasts: From Fundamental to Novel Applications
Hatoum, R., Labrie, S., & Fliss, I. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00421 · Cited by 338
Antimicrobial peptides and gut microbiota in homeostasis and pathology
Ostaff, M. J., Stange, E. F., & Wehkamp, J. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201773 · Cited by 329
Metadata
- Authors
- POTHOULAKIS, C.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2009-09-16
- Volume
- 30
- Issue
- 8
- Pages
- 826-833
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2038306583
- Cited by
- 164
- References
- 3
- FWCI
- 14.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: anti‐inflammatory mechanisms of action of Saccharomyces boulardii. https://app.cochat.ai/papers/10.1111/j.1365-2036.2009.04102.x
- The paper
- POTHOULAKIS, C. (2009). Review article: anti‐inflammatory mechanisms of action of Saccharomyces boulardii. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2009.04102.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.